Glaucoma is a leading cause of blindness. A range of surgical interventions exist for treating glaucoma, including a group of procedures commonly called micro-invasive or minimally invasive glaucoma surgery (MIGS). It has been noted that there is a growing demand for and use of MIGS procedures across Canada. At the same time, the cost of MIGS implantable devices can be considerable and inconsistencies appear to exist in some jurisdictions regarding coverage under the public health insurance plan.
CADTH, in collaboration with Health Quality Ontario, is undertaking an Optimal Use project to assess the clinical and cost-effectiveness as well as safety of, and patient experiences with MIGS for adults with glaucoma. Ethical and implementation issues will also be addressed.
Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies and expected completion dates may change. Find out more about Projects in Progress.
The “Projects in Progress” page on the CADTH website is updated on a seven- to eight-day cycle. Please be advised that there may be overlap between when a new report is posted online and when the section is updated. View our current Projects in Progress.
eye, filtering surgery, glaucoma, glaucoma drainage implants, microsurgery, minimally invasive surgical procedures, ophthalmologic surgical procedures, ophthalmology, sclerostomy, stents, trabeculectomy, medical devices, surgery, Antiglaucoma, MIGS, Minimally Invasive, OAG, POAG, Stent, eyes, micro, ocular, shunt, shunts